MeasuredReferencePonatinib targets ABL1, ABL2_ARG, BLK. Strongest hallmark effect: tumor promoting inflammation.
Top hallmarks
- tumor promoting inflammation7.5k
- proliferation5.6k
- evading apoptosis5.5k
Top pathways disrupted
- pi3k akt mtor signaling14.1k
- apical junction13.7k
- allograft rejection12.4k
Resistance landscape — Ponatinib
MeasuredReference10 known oncogenic variants exist on Ponatinib's top targets — see detail for inhibition impact.